Partner Content: Highlights
Top videos
Events & Jobs
Upcoming events
Current jobs
Current CME continuing education
View Post

What screening tools are helpful?

In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in need of palliative support in an accurate and needs-based manner, as recommended in guidelines. In the context of Germany and Switzerland, a distinction is made between general palliative care (APV) and specialized palliative care (SPV)…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post

Treatment of comorbidities in older people

One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25 years. Among older people with diabetes, 30–45% are affected by frailty. The risk of frailty increases with increasing HbA1c. The incidence of atherosclerotic cardiovascular disease (ASCVD) doubles with age, with a prevalence of 38.5% for coronary heart disease (CHD), 13% for stroke and 12% for peripheral arterial disease (PAD) in people aged ≥70 years. In addition to their glucose-controlling effect, new antidiabetic drugs have organ-protective benefits and have brought about a paradigm shift in diabetology…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt…
View Post

From the β-cell to the center: the versatile role of amylin

Although amylin was discovered decades ago, its importance in everyday clinical practice has long been underestimated. New pharmacological developments are increasingly bringing amylin into the focus of diabetes and obesity therapy, and amylin analogs, some of which have already passed phase 3 clinical trials, are now among the most promising approaches in overweight and obesity pharmacotherapy…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post

Dr. ChatGPT: Large language models in everyday clinical practice

With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (LLMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here